Akoya Biosciences, Inc. AKYA 深 滬
等待開盤 08-18 09:30:00 美东时间
1.29
0.000
0.00%
華盛通- 最 高--
- 今 開--
- 成交量 0股
- 最 低 --
- 昨 收 1.29
- 總市值 6444.09万
- 52周最高 3.42
- 市盈率 靜 --
- 換手率 0.00%
- 52周最低 0.931
- 委 比 0.00%
- 總股本 4995.42万
- 歷史最高 28.956
- 量 比 0
- 振 幅 0.00%
- 歷史最低 0.931
- 每 手 1
- 風險率 0.71%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Quanterix Unveils Novel p-Tau 205 And 212 Biomarker Assays, Expanding Blood-Based Alzheimer's Detection Portfolio
Company highlights expanded capabilities following Akoya Biosciences Acquisition and Simoa® technology included in more than 55 posters and oral presentations at the annual conference demonstrating its impact on
07-28 19:20
Quanterix Terminates Certain Executives From Akoya Biosciences
Unity Software(U.US) reported fourth-quarter financial results after the market...
07-19 05:01
快讯 | Quanterix CORP - 7月14日，终止Akoya Biosciences的高管职务 - SEC文件
Quanterix Corp - on July 14, Terminates Executives of Akoya Biosciences - SEC F...
07-19 04:38
Akoya Biosciences Completes Merger and Nasdaq Delisting
Akoya Biosciences ( ($AKYA) ) has issued an update. On July 8, 2025, Akoya Bios...
07-08 21:43
Quanterix Completes Acquisition of Akoya Biosciences
An announcement from Quanterix ( ($QTRX) ) is now available. On July 8, 2025, Q...
07-08 21:28
Kent Lake Raises Concerns Over Quanterix's $20M Cash Commitment Terms Amid Akoya's $1.40/Shr Unsolicited Offer
Kent Lake PR LLC ("Kent Lake"), a holder of approximately 6.9% of the outstanding common stock of Quanterix Corporation ("Quanterix" or the "Company") (NASDAQ:QTRX), today issued the following statement regarding the
05-24 02:27
12 Health Care Stocks Moving In Wednesday's Intraday Session
Gainers Biodesix (NASDAQ:BDSX) shares increased by 72.6% to $0.47 during Wedne...
05-22 01:06
美股大行评级 | 摩根大通：维持网易"超配"评级，目标价升至135美元；瑞银上调达美航空评级至"买入"
<span> <meta content="no-referrer" name="referrer"></span><p>https://static-hk.hstong.com/public/forum-v2/status/icon/50267976/originalpic/1131517965561573377.png</p><span style="color:#999999;">编者按：每日追踪华尔街最新评级与目标价，挖掘潜力股投资机会。</span><blockquote> <p><span style="color:#fa1432;"><strong>今日重点评级关注</strong></span></p></blockquote><p>• HC Wainwright & Co.：维持Armata Pharmaceuticals(ARMP)"买入"评级，目标价从7美元升至9美元</p> <p>• 瑞银：维持爱芬奇(ANF)"买入"评级，目标价从115美
05-20 09:28
Canaccord Genuity Maintains Hold on Akoya Biosciences, Lowers Price Target to $1.08
Canaccord Genuity analyst Kyle Mikson maintains Akoya Biosciences (NASDAQ:AKYA) with a Hold and lowers the price target from $1.8 to $1.08.
05-19 23:13
